These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 16353286)
21. Individualized choice in prenatal diagnosis: the impact of karyotyping and standalone rapid aneuploidy detection on quality of life. Boormans EM; Birnie E; Oepkes D; Boekkooi PF; Bonsel GJ; van Lith JM; Prenat Diagn; 2010 Oct; 30(10):928-36. PubMed ID: 20730751 [TBL] [Abstract][Full Text] [Related]
22. Costs and effects of prenatal screening methods for Down syndrome and neural tube defects. Hoogendoorn M; Evers SM; Schielen PC; van Genugten ML; de Wit GA; Ament AJ Community Genet; 2008; 11(6):359-67. PubMed ID: 18690004 [TBL] [Abstract][Full Text] [Related]
23. [Application of fluorescence in situ hybridization to prenatal diagnosis of Down syndrome]. Wang M; Li QF; Qiao FY Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Jun; 22(3):317-9. PubMed ID: 15952125 [TBL] [Abstract][Full Text] [Related]
24. Communication of prenatal screening and diagnosis results to primary-care health professionals. Statham H; Solomou W; Green JM Public Health; 2003 Sep; 117(5):348-57. PubMed ID: 12909426 [TBL] [Abstract][Full Text] [Related]
25. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice. Rowe HJ; Fisher JR; Quinlivan JA Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):433-9. PubMed ID: 16953859 [TBL] [Abstract][Full Text] [Related]
26. Anxiety and prenatal testing: do women with soft ultrasound findings have increased anxiety compared to women with other indications for testing? Hoskovec J; Mastrobattista JM; Johnston D; Kerrigan A; Robbins-Furman P; Wicklund CA Prenat Diagn; 2008 Feb; 28(2):135-40. PubMed ID: 18236427 [TBL] [Abstract][Full Text] [Related]
27. Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome. Jaques AM; Sheffield LJ; Halliday JL Prenat Diagn; 2005 Aug; 25(8):656-64. PubMed ID: 16049990 [TBL] [Abstract][Full Text] [Related]
28. A prospective study on the effect of rapid aneuploidy testing (amnio-PCR) on anxiety levels and quality of life measures in women and their partners with positive Down screening result. Leung WC; Lau ET; Ngai C; Lam H; Leung KY; Lee CP; Lao TT; Tang MH Fetal Diagn Ther; 2008; 24(3):165-9. PubMed ID: 18753751 [TBL] [Abstract][Full Text] [Related]
29. Rapid prenatal karyotyping using foetal blood obtained by cordocentesis. Mathur R; Dubey S; Hamilton S; Singh G; Deka D; Kriplani A; Kabra M; Menon PS Natl Med J India; 2002; 15(2):75-7. PubMed ID: 12044120 [TBL] [Abstract][Full Text] [Related]
30. [Analytic study of amniocentesis in prenatal genetic diagnosis. Transversal study of cases]. Garza Fernández L; Cabra Zurita R; Grether P; García León F; Kably Ambe A Ginecol Obstet Mex; 1998 Jun; 66():237-41. PubMed ID: 9679399 [TBL] [Abstract][Full Text] [Related]
31. Chromosome analysis of uncultured amniocytes by comparative genomic hybridization in early amniocentesis. Ketupanya A; Aranyakasemsuk N; Tocharoentanaphol C; Vuthiwong C J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S1-6. PubMed ID: 16862671 [TBL] [Abstract][Full Text] [Related]
32. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome]. Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480 [TBL] [Abstract][Full Text] [Related]
33. Fetal therapy and cytogenetic testing: prenatal detection of chromosome aberration during thoracocentesis for congenital chylothorax by karyotyping from pleural effusion fluid and review of the literature. Chen CP Genet Couns; 2005; 16(3):301-5. PubMed ID: 16259328 [TBL] [Abstract][Full Text] [Related]
34. The quest for the perfect baby: why do Israeli women seek prenatal genetic testing? Remennick L Sociol Health Illn; 2006 Jan; 28(1):21-53. PubMed ID: 16509941 [TBL] [Abstract][Full Text] [Related]
35. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation. Sharda S; Phadke SR J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609 [TBL] [Abstract][Full Text] [Related]
36. Specificity of fetal tricuspid regurgitation in prediction of Down syndrome in Thai fetuses at 17-23 weeks of gestation. Anuwutnavin S; Wanitpongpan P; Chanprapaph P J Med Assoc Thai; 2009 Sep; 92(9):1123-30. PubMed ID: 19772169 [TBL] [Abstract][Full Text] [Related]
37. False-positive diagnosis of trisomy 21 using fluorescence in situ hybridisation (FISH) on uncultured amniotic fluid cells. George AM; Oei P; Winship I Prenat Diagn; 2003 Apr; 23(4):302-5. PubMed ID: 12673634 [TBL] [Abstract][Full Text] [Related]
38. Prenatal screening for Down syndrome: women's involvement in decision-making and their attitudes to screening. Seror V; Ville Y Prenat Diagn; 2009 Feb; 29(2):120-8. PubMed ID: 19123253 [TBL] [Abstract][Full Text] [Related]
39. Second-trimester prenatal screening for trisomy 21 using biochemical markers: a 7-year experience in one cytogenetic laboratory. Marical H; Douet-Guilbert N; Bages K; Collet M; Le Bris MJ; Morel F; De Braekeleer M Prenat Diagn; 2006 Apr; 26(4):308-12. PubMed ID: 16491510 [TBL] [Abstract][Full Text] [Related]
40. [Prenatal diagnosis of two pregnancies with risk of chromosomal disorders]. Cui YX; Huang B; Shi YC; Lu HY; Xia XY; Pan LJ; Huang YF Zhonghua Nan Ke Xue; 2007 Jul; 13(7):624-7. PubMed ID: 17725307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]